Indoxyl sulfate promotes vascular smooth muscle cell calcification via the JNK/Pit-1 pathway

References

• Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112–S119.
   PubMed Web of Science ®Google Scholar
• Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005;20:1048–1056.
   PubMed Web of Science ®Google Scholar
• Dhingra R, Sullivan L, Fox C, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007;167:879–885.
   PubMed Web of Science ®Google Scholar
• Kestenbaum BR, Adeney KL, de Boer IH, Ix JH, Shlipak MG, Siscovick DS. Incidence and progression of coronary calcification in chronic kidney disease: The multi-ethnic study of atherosclerosis. Kidney Int. 2009;76:991–998.
   PubMed Web of Science ®Google Scholar
• Tonelli M, Curhan G, Pfeffer M, et al. Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation. 2009;120:1784–1792. DOI: 10.1161
   PubMed Web of Science ®Google Scholar
• Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87:E10–E17.
   PubMed Web of Science ®Google Scholar
• Lau WL, Pai A, Moe SM, Giachelli CM. Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis. 2011;18:105–112.
   PubMed Web of Science ®Google Scholar
• Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: Key roles for calcium and phosphate. Circ Res. 2011;109:697–711.
   PubMed Web of Science ®Google Scholar
• Gonzalez M, Martínez R, Amador C, Michea L. Regulation of the sodium-phosphate cotransporter Pit-1 and its role in vascular calcification. Curr Vasc Pharmacol. 2009;7:506–512.
   PubMed Web of Science ®Google Scholar
• Boyer CJ, Baines AD, Beaulieu E, Beliveau R. Immunodetection of a type III sodium-dependent phosphate cotransporter in tissues and OK cells. Biochim Biophys Acta. 1998;1368:73–83.
   PubMed Web of Science ®Google Scholar
• Kavanaugh MP, Miller DG, Zhang W, et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA. 1994;91:7071–7075.
   PubMed Web of Science ®Google Scholar
• Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res. 2006;98:905–912.
   PubMed Web of Science ®Google Scholar
• Li X, Yang HY, Giachelli CM. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis. 2008;199:271–277.
   PubMed Web of Science ®Google Scholar
• Zavaczki E, Jeney V, Agarwal A, et al. Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int. 2011;80:731–739.
   PubMed Web of Science ®Google Scholar
• Derici U, E Nahas AM. Vascular calcifications in uremia: Old concepts and new insights. Semin Dial. 2006;19:60–68.
   PubMed Web of Science ®Google Scholar
• Barreto FC, Barreto DV, Liabeuf S, et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009;4:1551–1558.
   PubMed Web of Science ®Google Scholar
• Lin CJ, Liu HL, Pan CF, et al. Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease. Arch Med Res. 2012;43:451–456.
   PubMed Web of Science ®Google Scholar
• Tumur Z, Niwa T. Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells. Am J Nephrol. 2009;29:551–557.
   PubMed Web of Science ®Google Scholar
• Watanabe I, Tatebe J, Namba S, Koizumi M, Yamazaki J, Morita T. Activation of aryl hydrocarbon receptor mediates indoxyl sulfate-induced monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells. Circ J. 2013;77:224–230.
   PubMed Web of Science ®Google Scholar
• Taki K, Tsuruta Y, Niwa T. Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients. Am J Nephrol. 2007;27:30–35.
   PubMed Web of Science ®Google Scholar
• Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T. Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant. 2008;23:1892–1901.
   PubMed Web of Science ®Google Scholar
• Yisireyili M, Shimizu H, Saito S, Enomoto A, Nishijima F, Niwa T. Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats. Life Sci. 2013;92:1180–1185.
   PubMed Web of Science ®Google Scholar
• Muteliefu G, Enomoto A, Jiang P, Takahashi M, Niwa T. Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells. Nephrol Dial Transplant. 2009;24:2051–2058.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Bolati D, Higashiyama Y, Nishijima F, Shimizu K, Niwa T. Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-κB, p53, ERK, and JNK in proximal tubular cells. Life Sci. 2012;90:525–530.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Ghayor C, Guicheux J, et al. Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J Bone Miner Res. 2006;21:674–683.
   PubMed Web of Science ®Google Scholar
• Rossi M, Campbell KL, Johnson DW, et al. Protein-bound uremic toxins, inflammation and oxidative stress: Across-sectional study in stage 3-4 chronic kidney disease. Arch Med Res. 2014;45:309–317.
   PubMed Web of Science ®Google Scholar
• Lin CY, Hsu S.C, Lee HS, et al. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. J Vasc Surg. 2013;57:475–485.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Hirose Y, Goto S, et al. Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells. Life Sci. 2012;91:172–177.
   PubMed Web of Science ®Google Scholar
• Goto S, Kitamura K, Kono K, Nakai K, Fujii H, Nishi S. Association between AST-120 and abdominal aortic calcification in predialysis patients with chronic kidney disease. Clin Exp Nephrol. 2013;17:365–371.
   PubMed Web of Science ®Google Scholar
• Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsukushi S, Tsutsui S. The protein metabolite hypothesis, a model for the progression of renal failure: An oral adsorbent lowers indoxyl sulfate levels in undialyzed uraemic patients. Kidney Int. 1997;52:S23–S28.
   Web of Science ®Google Scholar
• Salaun C, Leroy C, Rousseau A, Boitez V, Beck L, Friedlander G. Identification of a novel transport-independent function of PiT1/SLC20A1 in the regulation of TNF-induced apoptosis. J Biol Chem. 2010;285:34408–34418.
   PubMed Web of Science ®Google Scholar
• Bolati D, Shimizu H, Yisireyili M, Nishijima F, Niwa T. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB. BMC Nephrol. 2013;14:56.
   PubMed Web of Science ®Google Scholar
• Niwa T, Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med. 1994;124:96–104.
   PubMed Web of Science ®Google Scholar
• Niwa T, Miyazaki T, Tsukushi S, et al. Accumulation of indoxyl-beta-D-glucuronide in uremic serum: Suppression of its production by oral sorbent and efficient removal by hemodialysis. Nephron. 1996;74:72–78.
   PubMed Web of Science ®Google Scholar